secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K/A
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001104659-24-058808
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie approves CEO compensation for Robert Michael; shareholders reject supermajority repeal
--------------------------------------------------------------------------------

- CEO-elect Robert Michael base salary set at $1.7M with target bonus of 150% of base, effective July 1, 2024.
- Outgoing CEO Richard Gonzalez receives $1.5M base salary as Executive Chairman, target bonus 140% of base.
- Shareholders approved all directors and say-on-pay advisory vote (annual basis) with majority support.
- Proposal to eliminate supermajority voting failed with 1.249B for, 21.4M against, but required supermajority not met.
- Stockholder proposals on simple majority voting, lobbying report, and patent report all rejected with over 900M against each.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465924058808/0001104659-24-058808-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465924058808/tm2413796d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-058808

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer